JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody
about
A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in PigsDelta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza VaccineAdvax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protectionAdvax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.Inulin isoforms differ by repeated additions of one crystal unit cell.A New Clade of Insect-Specific Flaviviruses from Australian Anopheles Mosquitoes Displays Species-Specific Host RestrictionA single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protectionImmunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling.Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foalsCD8+ T cells complement antibodies in protecting against yellow fever virus.Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyInternal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine propertiesAdvax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain.Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection.DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.Memory B cells: a proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine.Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant.Zika virus vaccines
P2860
Q30250935-8A7DDA77-045B-4CFC-AE65-3B52C27292EBQ30376743-3B2A8B51-B08E-4BD2-B9E5-F9E41E21B43CQ30377381-65E6AB19-7F4D-4317-986B-2F934F75034EQ30379559-DC2F69B4-E19F-45A4-99F0-5F72DF42D2BAQ30389743-21A03E96-0A50-4B80-93D9-677467FC05DAQ30655287-38EBE122-2A8A-4ED6-9EBD-EACD1B21F190Q33718615-ED75CC65-DBDE-42D5-9603-0156DB8FBEB6Q33735067-40F6B382-DAE8-4181-B30E-160E81696787Q33896177-4C2FE25C-A550-4351-9561-43726949B948Q33940730-42D77A06-C434-4B4B-AA5E-9A758C36872DQ34621859-FAD6D83A-850F-4647-9A3A-448ECF79E03CQ34719089-6BB1DA15-8E3F-4E24-BD15-3B8B5BCC15ACQ34720701-B03EF479-8681-42ED-9C4F-AE5D74FC5F3BQ34980404-A35DAB51-6A50-4AC1-8656-38E85814436AQ35111000-1510007D-DE4C-4939-9E03-5EAB46C6D442Q35799379-227FDDD0-031C-46B4-B3CA-F079EF725887Q35893171-52DD4FC2-570F-4861-8783-E48BB925DAB3Q37123147-2BDB3C75-1998-4FF8-8023-B44322ADE521Q37547088-C7C62E67-E6E9-4689-8B1D-F910C2B1529DQ37584248-BD9B50A6-164C-4AA7-A698-4FC53C358F51Q39311849-47BCA2A1-AA5B-4D32-8BC4-EB40337A57D2Q40089069-ED30EEFD-887F-4A3A-8927-B3BD16CEA2CFQ40101584-B1794A47-A60F-4E6A-B253-402F44D812ABQ40237994-6C62A6A2-81B3-40A1-997C-C53B9B610F09Q40715781-915881F9-5AEB-4FE3-B8E9-8D6EF41FF314Q56354521-0CCE6C35-D638-43C6-AA3F-F4A565E63F36
P2860
JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@ast
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@en
type
label
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@ast
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@en
prefLabel
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@ast
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@en
P2860
P50
P356
P1433
P1476
JE-ADVAX vaccine protection ag ...... exposure neutralizing antibody
@en
P2093
Mario Lobigs
Roy A Hall
P2860
P304
P356
10.1128/JVI.03144-12
P407
P577
2013-02-06T00:00:00Z